Clinical TrialsSearch results
Number of results: 535
- Recruitment status
- Title of the study
- Health Condition
- Primary sponsor
- Date of registration
Recruiting
- A Feasibility Study of Case Management by Psychiatric Care Providers to Improve Access to Cancer Screening for Patients with Schizophrenia in Usual Clinical Practice
- Schizophrenia (including Schizoaffective disorder), Cancer
- Fujiwara Masaki
- 2022-06-04
Other
- A multicenter study on early prediction of antipsychotic response in patients with schizophrenia
- schizophrenia
- Juntendo University School of Medicine
- 2009-06-01
Recruiting
- A study of aminolevulinic acid phosphate as an aid to functional recovery in patients with sarcopenia
- Sarcopenia
- Sugimoto Ken
- 2024-09-13
Other
- Phase2 Study of Glivec (imatinib mesylate, formerly known as STI571) in Patients with Relapsed or Refractory Sarcomas with c-kit or PDGFR Expression
- Sarcoma with c-kit or PDGFR expression by immunohistochemistry
- Office of Imatinib phase2 study
- 2005-08-22
No Longer Recruiting
- The efficacy of delgocitinib ointment for rosacea and rosacea-like dermatitis
- rosacea, rosacea-like dermatitis
- Kajita Ai
- 2022-02-22
Other
- Safety of Biologics in Clinical Use in Japanese Patients with Rheumatoid Arthritis in Long-Term (SECURE)
- Rheumatoid Arthritis
- Japan College of Rheumatology
- 2008-09-01
Recruiting
- pembrolizumab plus axitinib trial
- renal cell carcinoma
- Takehiro Iawata
- 2021-03-16
Other
- Multi-institute randomized study of natural type interferon alpha for patients with renal cell carcinoma after radical nephrectomy
- Renal cell carcinoma
- TRAIn-Alpha study group
- 2005-09-30
Other
- Multi-Center Phase II Study on Efficacy of High-Slip Skin Care Pad for Hand-Foot Skin Reaction Caused by Sorafenib in Patients with Renal Cell Carcinoma
- Renal cell carcinoma
- Japanese Society of Renal Cancer (JSRC)
- 2009-05-29
Other
- A Phase 2 Study of Tarlatamab in Patients With Small Cell Lung Cancer (SCLC)
- Relapsed/Refractory Small Cell Lung Cancer
- Tagashira Shuzo
- 2022-02-19